Chen Y, Gross P, Ramakrishna V, Rabitz H, Mease K, Singh H. (1995). Competitive tracking of molecular objectives described by quantum mechanics. Journal of Chemical Physics 102, 8001-8010.

Chen Y, Gross P, Ramakrishna V, Rabitz H, Mease K, Singh H. (1996). Selective excitation of molecular eigenstates using state-dependent optical field design. Chemical Physics Letters 252, 447-456.

Chen Y, Gross P, Ramakrishna V, Rabitz H, Mease K, Singh H. (1997). Control of classical regime molecular objectives - applications of tracking and Variations of the theme. Automatica 33, 1617-1633.

Altan N, Chen Y, Schindler M, Simon S.M. (1998). Defective acidification in human breast tumor cells and implications for chemotherapy. Journal of Experimental Medicine 187, 1583-1598.

Altan N.1, Chen Y.1, Schindler M, Simon S.M. (1999). Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proceedings of the National Academy of Sciences of the United States of America 96, 4432-4437.

Chen Y, Schindler M, Simon S.M. (1999). A mechanism for tamoxifen-mediated inhibition of acidification. Journal of Biological Chemistry 274, 18364-18373.

Chen Y, Simon S.M. (2000). In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity. The Journal of Cell Biology 148, 863-870.

Chen Y, Pant C. P, and Simon S. M. (2001). P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells. Cancer Research 61, 7763-7769.

Rajagopal A, Pant  CP, Simon SM and Chen Y. (2002). In vivo analysis of human multidrug resistance protein (MRP1) activity using transient expression of fluorescently tagged MRP1. Cancer Research 62, 391-396.

Ghia KK, Chen Y, Milner DA, Fisher DC. (2004). Challenging manifestations of malignancies. Case 2. Langerhans cell histiocytosis presenting with a skin rash. Journal of Clinical Oncology. 22, 3640-3642.

Chen Y, Sawyers CL. (2008). Molecular Biology of Prostate Cancer. In: Devita VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 8 ed. Philadelphia: Lippincott Williams & Wilkins; 1385-91.

Chen Y, Sawyers CL, Scher HI. (2008). Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol 8, 440-448.

Welsbie D1, Xu J 1, Chen Y1, , Borsu L, Scher HI, Rosen N, Sawyers CL. (2009). Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer. Cancer Research 69, 958-66.

Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A, Wasielewska T, Welsbie D, Chen C, Higano CS, Beer TM, Hung DT, Scher HI, Jung M, Sawyers CL. (2009). Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer. Science 324, 787-90.

Chen Y, Clegg NJ, Scher HI. (2009). Antiandrogens and androgen depleting therapies in prostate cancer: novel agents for an established target. Lancet Oncology 10, 981-91.

Chen Y, Sawyers CL. (2010). Coordinate transcriptional regulation by ERG and androgen receptor in fusion-positive prostate cancers. Cancer Cell 17, 415-6.

Chi P 1, Chen Y 1, Zhang L, Wongvipat J, Shamu T, Fletcher J, Maki R, Antonescu C, Allis CD, Sawyers CL. (2010). ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 467, 849-53. Featured in “News and Views”.

Chen Y, Arora VK, Sawyers CL. (2011). Molecular Biology of Prostate Cancer. In: Devita VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 9 ed. Philadelphia: Lippincott Williams & Wilkins.

Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher HI, Scardino PT, Rosen N, Sawyers CL. (2011). Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer. Cancer Cell 19, 575-86.

Chen Y, Shamu T, Chen H, Besmer P, Sawyers CL, Chi P. (2011) Visualization of the Interstitial Cells of Cajal (ICC) Network in Mice. J Vis Exp. Jul 27;(53).

Chen Y, Scher HI. (2012) Prostate cancer in 2011: Hitting old targets better and identifying new targets. Nat Rev Clin Oncol. 9:70.

Clegg NJ, Wongvipat J, Tran C, Ouk S, Dilhas A, Joseph J, Chen Y, Grillot K, Bischoff ED, Cai L, Aparicio A, Dorow S, Arora V, Shao G, Qian J, Zhao H, Yang G, Cao C, Sensintaffar J, Wasielewska T, Herbert MR, Bonnefous C, Darimont B, Scher HI, Smith-Jones PM, Klang M, Smith ND, de Stanchina E, Wu N, Ouerfelli O, Rix P, Heyman R, Jung ME, Sawyers CL, Hager JH. (2012) ARN-509: a novel anti-androgen for prostate cancer treatment. Cancer Res. [Epub ahead of print]